Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval ABX Abacus Global posts Q4 2025 earnings per share 186 percent above consensus estimates as shares stay flat How is the market affecting The GLUA stock today